Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -3.812% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a COCCOC(=O)c1sc2nc[nH]c(=O)c2c1C
b O=C(NCC1CCCO1)C(=Cc1cccc([N+](=O)[O-])c1)C(=O)NCC1CCCO1
c N#CC1=C(N2CCCCC2)c2cc3c(n2C1=O)CCCC3
d COC(=O)C1=C(C)N(C)C(=S)NC1c1ccc(Cl)cc1
Answer: d. COC(=O)C1=C(C)N(C)C(=S)NC1c1ccc(Cl)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)C1=C(C)N(C)C(=S)NC1c1ccc(Cl)cc1
COC(=O)C1=C(C)N(C)C(=S)NC1c1ccc(Cl)cc1
methyl 6-(4-chlorophenyl)-3,4-dimethyl-2-sulfanylidene-1,6-dihydropyrimidine-5-carboxylate